XML 100 R89.htm IDEA: XBRL DOCUMENT
v3.23.1

SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended
--- | ---
Mar. 31, 2023 | Mar. 31, 2022
Disaggregation of Revenue [Line Items] |  |
Revenues | $ 1,944 | $ 1,918
Pharmaceuticals |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 823 | 834
Devices |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 479 | 458
OTC |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 394 | 376
Branded and Other Generics |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 226 | 223
Other revenues |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 22 | 27
Salix |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 496 | 464
Salix | Pharmaceuticals |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 496 | 464
Salix | Devices |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Salix | OTC |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Salix | Branded and Other Generics |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Salix | Other revenues |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
International |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 247 | 244
International | Pharmaceuticals |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 57 | 58
International | Devices |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
International | OTC |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 39 | 38
International | Branded and Other Generics |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 138 | 133
International | Other revenues |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 13 | 15
Solta Medical |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 73 | 72
Solta Medical | Pharmaceuticals |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Solta Medical | Devices |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 73 | 72
Solta Medical | OTC |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Solta Medical | Branded and Other Generics |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Solta Medical | Other revenues |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Diversified |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 197 | 249
Diversified | Pharmaceuticals |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 162 | 205
Diversified | Devices |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 0 | 0
Diversified | OTC |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 2 | 2
Diversified | Branded and Other Generics |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 27 | 36
Diversified | Other revenues |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 6 | 6
Bausch + Lomb |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 931 | 889
Bausch + Lomb | Pharmaceuticals |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 108 | 107
Bausch + Lomb | Devices |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 406 | 386
Bausch + Lomb | OTC |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 353 | 336
Bausch + Lomb | Branded and Other Generics |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | 61 | 54
Bausch + Lomb | Other revenues |  |
Disaggregation of Revenue [Line Items] |  |
Revenues | $ 3 | $ 6

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=bhc_PharmaceuticalProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bhc_DeviceProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bhc_OvertheCounterProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bhc_BrandedandOtherGenericProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bhc_OtherRevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bhc_SalixSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bhc_InternationalRxMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bhc_SoltaMedicalSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bhc_DiversifiedSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bhc_BauschLombMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |